{
    "nctId": "NCT06559696",
    "briefTitle": "Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy",
    "officialTitle": "Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy: a Phase III Randomized, Controlled Clinical Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 722,
    "primaryOutcomeMeasure": "Disease free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed invasive breast cancer\n* Underwent neoadjuvant chemotherapy\n* Eastern Cooperative Oncology Group Performance Status Scale 0-2\n* ypN+ after neoadjuvant chemotherapy or supraclavicular/subclavicular lymph node metastasis before system therapy\n* No distant metastases\n* No internal mammary nodes metastases based on images before system therapy\n* Willing to follow up\n* Written,informed consent\n\nExclusion Criteria:\n\n* Without neoadjuvant chemotherapy\n* Distant metastases\n* Simultaneous bilateral breast cancer\n* Pathological confirmation or imaging consideration of lymph node metastasis in the internal mammary before system therapy\n* Had simultaneous or previous secondary malignancies, except for non-malignant melanoma skin cancer, papillary thyroid / follicular carcinoma, cervical carcinoma in situ, contralateral non-invasive breast cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}